His primary scientific interests are in Idiopathic pulmonary fibrosis, Internal medicine, Pulmonary fibrosis, Respiratory disease and Interstitial lung disease. His biological study spans a wide range of topics, including Lung biopsy and Intensive care medicine. The Internal medicine study combines topics in areas such as Gastroenterology and Surgery.
In his research, Combined pulmonary fibrosis and emphysema is intimately related to Cardiology, which falls under the overarching field of Pulmonary fibrosis. His studies in Respiratory disease integrate themes in fields like Radiology, Computed tomography, Lung volumes and Bronchiectasis. His work carried out in the field of Interstitial lung disease brings together such families of science as Vital capacity, Hypersensitivity pneumonitis and Immunology.
Athol U. Wells mainly focuses on Internal medicine, Idiopathic pulmonary fibrosis, Interstitial lung disease, Pathology and Lung. The concepts of his Internal medicine study are interwoven with issues in Gastroenterology and Cardiology. His research integrates issues of Pulmonary fibrosis, Vital capacity, Surgery and Intensive care medicine in his study of Idiopathic pulmonary fibrosis.
Athol U. Wells interconnects Disease and MEDLINE in the investigation of issues within Intensive care medicine. His research in Interstitial lung disease intersects with topics in Scleroderma, Radiology, Pulmonary function testing, Physical therapy and Cohort. His work deals with themes such as Idiopathic interstitial pneumonia and Respiratory system, which intersect with Pathology.
Athol U. Wells mainly investigates Internal medicine, Idiopathic pulmonary fibrosis, Interstitial lung disease, Lung and In patient. Many of his studies involve connections with topics such as Gastroenterology and Internal medicine. Athol U. Wells has researched Idiopathic pulmonary fibrosis in several fields, including Vital capacity, Respiratory system and Clinical trial.
Athol U. Wells combines subjects such as Intensive care medicine, Connective tissue, Pathology and MEDLINE with his study of Interstitial lung disease. The various areas that he examines in his Intensive care medicine study include Sarcoidosis and Disease. His studies deal with areas such as Natural history and Biopsy, Radiology as well as Lung.
The scientist’s investigation covers issues in Idiopathic pulmonary fibrosis, Internal medicine, Interstitial lung disease, Lung and FEV1/FVC ratio. His Idiopathic pulmonary fibrosis study focuses on Usual interstitial pneumonia in particular. His Internal medicine study frequently links to related topics such as Placebo.
His work on Idiopathic interstitial pneumonia as part of general Interstitial lung disease study is frequently linked to In patient, therefore connecting diverse disciplines of science. His Lung research incorporates elements of Pathological, Disease, Pathology and Pneumonia. His FEV1/FVC ratio research incorporates themes from Lung volumes and Hazard ratio.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
An Official ATS/ERS/JRS/ALAT Statement: Idiopathic Pulmonary Fibrosis: Evidence-Based Guidelines for Diagnosis and Management
Ganesh Raghu;Harold R. Collard;Jim J. Egan;Fernando J. Martinez.
American Journal of Respiratory and Critical Care Medicine (2011)
American thoracic society/European respiratory society international multidisciplinary consensus classification of the idiopathic interstitial pneumonias
William D. Travis;Talmadge E. King;Eric D. Bateman;David A. Lynch.
American Journal of Respiratory and Critical Care Medicine (2002)
An Official American Thoracic Society/European Respiratory Society Statement: Update of the International Multidisciplinary Classification of the Idiopathic Interstitial Pneumonias
William D. Travis;Ulrich Costabel;David M. Hansell;Talmadge E. King.
American Journal of Respiratory and Critical Care Medicine (2013)
Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline.
Ganesh Raghu;Martine Remy-Jardin;Jeffrey L. Myers;Luca Richeldi.
American Journal of Respiratory and Critical Care Medicine (2018)
The Role of Chest Imaging in Patient Management during the COVID-19 Pandemic: A Multinational Consensus Statement from the Fleischner Society
Geoffrey D. Rubin;Christopher J. Ryerson;Linda B. Haramati;Nicola Sverzellati.
Acute Exacerbations of Idiopathic Pulmonary Fibrosis
Harold R. Collard;Bethany B. Moore;Kevin R. Flaherty;Kevin K. Brown.
American Journal of Respiratory and Critical Care Medicine (2007)
An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline: Treatment of Idiopathic Pulmonary Fibrosis. An Update of the 2011 Clinical Practice Guideline
Ganesh Raghu;Bram Rochwerg;Yuan Zhang;Carlos A. Cuello Garcia.
American Journal of Respiratory and Critical Care Medicine (2015)
Interstitial lung disease in systemic sclerosis: a simple staging system.
Nicole S. L. Goh;Sujal R. Desai;Srihari Veeraraghavan;David M. Hansell.
American Journal of Respiratory and Critical Care Medicine (2008)
Interstitial lung disease guideline: the British Thoracic Society in collaboration with the Thoracic Society of Australia and New Zealand and the Irish Thoracic Society.
A U Wells;N Hirani.
Nintedanib in Progressive Fibrosing Interstitial Lung Diseases
Kevin R Flaherty;Athol U Wells;Kevin K Brown.
The New England Journal of Medicine (2019)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: